Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Columnists

About Gail Dutton

Gail Dutton
Gail Dutton, The Life Sciences Report

Gail Dutton's Most Recent Articles

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being...

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being...

Gail Dutton | December 23, 2015

Clinton's Price Caps Are a Non-Starter: Liana Moussatos of Wedbush Securities

Gail Dutton | November 25, 2015

Robotics Are Key to New Millennium Surgeries: Hansen Medical's Cary Vance

Gail Dutton | November 18, 2015

Aethlon Medical's biofiltration platform tackles everything from ebola to cancer: CEO James Joyce

Gail Dutton | October 30, 2015

Eight ways to leverage the small-cap biotech bull market: Ajay Tandon and Jay Albany of...

Gail Dutton | October 30, 2015

OTC strategy supports cobra venom pipeline in Asia and North America: Nutra Pharma's Rik Deitsch

Gail Dutton | October 22, 2015

Delivering the triple whammy that makes stem cell therapies commercially viable: Cynata...

Gail Dutton | October 15, 2015

Use stock volatility to invest in innovative oncology companies: JMP Security's Michael King Jr.

Gail Dutton | October 15, 2015

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton | October 1, 2015

CAR T-cell therapeutics: Alan Leong of BioWatch looks beyond the buzz for solid early-stage plays

Gail Dutton | September 10, 2015
1 2 Next